abstract |
The present invention provides benzamide compounds, compositions containing such benzamides, and uses of such benzamides for inhibiting the androgen receptor (AR) and/or aldo-ketoreductase family 1 member C3 (AKR1C3). Also described herein are methods for the treatment of hormone-mediated diseases and conditions, including hormone-related cancers such as castration-resistant prostate cancer. |